User profiles for GEORGIOS POLYCHRONIDIS

Georgios Polychronidis, MD, Dr.med.

Harvard TH Chan School of Public Health
Verified email at hsph.harvard.edu
Cited by 660

[HTML][HTML] HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon

…, C Dächert, B Schusser, R Koschny, G Polychronidis… - Gastroenterology, 2018 - Elsevier
Background & Aims Hepatitis C virus (HCV) infection is sensitive to interferon (IFN)-based
therapy, whereas hepatitis B virus (HBV) infection is not. It is unclear whether HBV escapes …

Immune-mediated diseases associated with cancer risks

M He, CH Lo, K Wang, G Polychronidis, L Wang… - JAMA …, 2022 - jamanetwork.com
Importance Immune regulation is important for carcinogenesis; however, the cancer risk
profiles associated with immune-mediated diseases need further characterization. Objective To …

[HTML][HTML] Incidence trends and survival prediction of hepatoblastoma in children: a population-based study

J Feng, G Polychronidis, U Heger, G Frongia… - Cancer …, 2019 - Springer
Background Hepatoblastoma is a rare disease that nevertheless accounts for the majority of
liver malignancies in children. Due to limited epidemiological data, therapy for …

Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank

…, D Hang, F Wang, G Polychronidis… - … journal of cancer, 2021 - Wiley Online Library
Evidence links the liver to development of colorectal cancer (CRC). However, it remains
unknown how liver function may influence CRC risk in the general population. We conducted a …

Association of gallstone disease with risk of colorectal cancer: a systematic review and meta-analysis of observational studies

G Polychronidis, H Siddiqi, F Ali Ahmed… - International Journal …, 2023 - academic.oup.com
Background Numerous studies have assessed the association of gallstones or cholecystectomy
(CE) with risk of colorectal cancer (CRC). However, the findings are mixed. Objective To …

Periodontal disease, tooth loss, and risk of oesophageal and gastric adenocarcinoma: a prospective study

CH Lo, S Kwon, L Wang, G Polychronidis, MD Knudsen… - Gut, 2021 - gut.bmj.com
We read with great interest the study by Coker et al 1 that provided supportive evidence for
the role of oral microbiota in gastric cancer. A few studies also highlighted the possible link …

[HTML][HTML] Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects—results from the POUDER pilot study

VJ Lozanovski, G Polychronidis, W Gross… - Investigational new …, 2020 - Springer
Pancreatic ductal adenocarcinoma is a highly aggressive malignancy with short survival and
limited therapeutic options. Broccoli sulforaphane is a promising new treatment due to the …

Kinetic validation of the LiMAx test during 10 000 intravenous 13C-methacetin breath tests

…, FWR Vondran, G Polychronidis… - Journal of breath …, 2017 - iopscience.iop.org
The maximal liver function capacity (LiMAx) test, a novel 13 C-methacetin breath test, has
proven clinical validity in determining hepatic metabolic capacity. In contrast to prior 13 C-…

Prognostic role of BRAF mutations in colorectal cancer liver metastases

…, K Sasaki, A Angelou, G Polychronidis… - Anticancer …, 2016 - ar.iiarjournals.org
Background/Aims: The impact of tumor biology on prognosis in patients with colorectal liver
metastasis (CRLM) has been the topic of intense research. Specifically, the presence of …

[HTML][HTML] Development and validation of a risk prediction model for post-polypectomy colorectal cancer in the USA: a prospective cohort study

MD Knudsen, K Wang, L Wang, G Polychronidis… - …, 2023 - thelancet.com
Background Effective risk stratification tools for post-polypectomy colorectal cancer (PPCRC)
are lacking. We aimed to develop an effective risk stratification tool for the prediction of …